Primer Açık Açılı Glokomlu ve Oküler Hipertansiyonlu Hastalarda Risk Faktörlerinin Değerlendirilmesi

Year 2024, Volume: 19 Issue: 3, 103 - 108, 04.11.2024

Ömer Ekici , Mehmet Okka , Ahmet Özkağnıcı

https://doi.org/10.17517/ksutfd.1356554

Abstract

Amaç: Primer açık açılı glokomlu (PAAG) olguları ve Oküler Hipertansiyonlu (OHT) olguları yaş, cinsiyet, göz içi basıncı (GİB), santral kornea kalınlığı (SKK), sferik ekivalan değeri, sigara içiciliği, aile hikayesi ve ek sistemik hastalık mevcudiyeti açısından karşılaştırmak ve bu verilerin birbiriyle olan ilişkisini değerlendirmek.
Gereç ve Yöntemler: 40 PAAG'li ve 40 OHT'li olgu, hasta grubu ve glokomu olmayan 40 olgu kontrol grubu olarak kabul edildi. Yaş, cinsiyet, GİB, SKK, sferik ekivalan değeri, soygeçmişte glokom hikayesi, ebeveynler arası akraba evliliği hikayesi, sigara kullanımı ve ilave sistemik hastalıklar kaydedildi.
Bulgular: Cinsiyet dağılımı ve yaş ortalaması açısından gruplar arasında anlamlı fark görülmedi. PAAG ve OHT gruplarında GİB kontrol grubuna göre anlamlı olarak yüksek iken PAAG ve OHT grupları arasındaki fark ise anlamlı değildi. OHT grubunda ortalama SKK değeri, PAAG ve kontrol gruplarına göre anlamlı olarak daha yüksekti. GİB ile SKK arasında istatistiksel analizde anlamlı korelasyon tespit edilmedi. Sferik ekivalan ortalama değerleri yönünden gruplar arasında anlamlı bir fark saptanmadı. Hipertansiyon, diyabetes mellitus, koroner arter hastalığı insidansı yönünden gruplar arasında farklılık yoktu. PAAG ve OHT gruplarında pozitif aile hikayesi oranı, kontrol grubuna göre anlamlı yüksekti. Gruplar arasında akraba evliliği hikayesi yönünden anlamlı fark tespit edilmedi. Sigara kullanım öyküsü açısından gruplar arasında anlamlı fark izlenmedi.
Sonuç: PAAG ve OHT gruplarında yüksek GİB en önemli risk faktörüdür. PAAG ve OHT gruplarında anlamlı derecede ailesel glokom öyküsüne rastlanması genetik faktörlerin önemli bir risk faktörü olabileceğini göstermektedir.

Keywords

Kornea kalınlığı , miyopi , oküler hipertansiyon , primer açık açılı glokom , sigara

Evaluation of Risk Factors in Patients with Primary Open Angle Glaucoma and Ocular Hypertension

Abstract

Objective: The purpose of our study was to compare the age, gender, intraocular pressure (IOP), central corneal thickness (CCT), spherical equivalent values, smoking, family history of glaucoma, and additional systemic diseases in patients with primary open-angle glaucoma (POAG) and patients with ocular hypertension (OHT); and to evaluate the relationships of these factors with each other.
Materials and Methods: 40 patients with POAG, 40 patients with OHT, and 40 individuals as a control group were included in the study. Age, gender, IOP, CCT, spherical equivalent values, family history of glaucoma, history of consanguineous marriage, smoking, and systemic diseases of each subject were recorded.
Results: There was no significant difference in gender and average age between the groups. IOP values were higher in the POAG and OHT groups than in the control group. There was no significant difference in IOP values between POAG and OHT groups. CCT was higher in the OHT group than in the other groups. There was no significant correlation between IOP and CCT values. There was no significant difference in mean spherical equivalent values. The incidence of hypertension, coronary heart disease, and diabetes mellitus was similar in all groups. Family history of glaucoma is increased in the POAG and OHT group compared with the control group. There was no significant difference in the history of consanguineous marriage, alcohol usage, and smoking status among all groups.
Conclusion: High IOP was the most important risk factor in POAG and OHT groups. A significant familial history of glaucoma in POAG and OHT groups suggests that genetic factors may be an important risk factor.

Keywords

Corneal thickness , myopia , ocular hypertension , primary open angle glaucoma , smoking

Ethical Statement

The study was approved by the Ethics Committee of Necmettin Erbakan University, Konya, Turkey (Protocol No: 2014/680) and all procedures were applied in accordance with the Declaration of Helsinki.

References

• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311: 1901–11.
• Le A, Mukesh BN, McCarty CA, et al. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci. 2003;44: 3783-9.
• Jonas JB, Aung T, Bourne RR, et al. Glaucoma. Lancet. 2017;390: 2183–93.
• Kanski JJ: Glokomlar: Klinik oftalmoloji, Dördüncü baskı. Çeviri Ed: Oraglı K:M: Great Britain Butterwortu-Heinemann LTD. 1999, S: 183-209.
• Nemesure B, Wu SY, Hennis A, Leske MC. Factors related to the 4-year risk of high intraocular pressure. The Barbados eye studies. Arch Ophthalmol. 2003;121(6): 856-62.
• Tielsch JM, Katz J, Sommer A. Family history and risk of primary open-angle glaucoma: The Baltimore Eye Survey. Arch Ophthalmol. 1994;112: 69-73.
• Leske MC, Nemesure B, He Q. Patterns of open-angle glaucoma in the Barbados Family Study. Ophthalmology. 2001;108: 1015-22.
• Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266(3): 369-74.
• Chen Y, Lin Y, Vithana EN, et al. Common variants near ABCA1 and PMM2 are associated with primary open-angle glaucoma. Nat. Genet. 2014;46: 1115–9.
• Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmol. 2007;114(9): 1779–87.
• Kass MA, Heuer DK, Higginbotham EJ. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 701-13.
• Haarman AEG, Enthoven CA, Tideman JWL, et al. The complications of myopia: A review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(4): 49.
• Ha A, Kim CY, Shim SR, et al. Degree of Myopia and Glaucoma Risk: A Dose-Response Meta-analysis. Am J Ophthalmol. 2022;236: 107-19.
• Goldacre MJ, Wotton CJ, Keenan TD. Risk of selected eye diseases in people admitted to the hospital for hypertension or diabetes mellitus: record linkage studies. Br J Ophthalmol. 2012;96: 872–6.
• Zhao D, Cho J, Kim MH, et al. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology. 2015;122: 72–8.
• Gordon MO, Beiser JA, Brandt JD. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary-open angle glaucoma. Arch Ophthalmol. 2002;120: 714-20.
• Bowe A, Grunig M, Schubert J, et al. Circadian variation in arterial blood pressure and glaucomatous optic neuropathy–A systematic review and meta-analysis. Am J Hypertens. 2015;28(9): 1077–82.
• Omodaka K, Kikawa T, Kabakura S, et al. Clinical characteristics of glaucoma patients with various risk factors. BMC Ophthalmol. 2022;22(1): 373.
• Caprioli J, Coleman AL. Perspective Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010;149: 704-12.
• Edwards R, Thornton J, Ajit R, et al. Cigarette smoking and primary open angle glaucoma: a systematic review. J Glaucoma. 2008;17(7): 558–66.
• Stuart KV, Madjedi K, Luben RN, et al. Modifiable Risk Factors for Glaucoma Collaboration. Alcohol, Intraocular Pressure, and Open-Angle Glaucoma: A Systematic Review and Meta-analysis. Ophthalmology. 2022;129(6): 637-52.
• Mukesh BN, McCarty CA, Raitj L, et al. Five year incidence of open angle glaucoma: the visual impairment Project glaucoma. Ophthalmology. 2002;109: 1047-51.
• Argus WA. Ocular hypertension and central corneal thickness. Elsevier. 1995;102: 1810-2.
• Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and visual function abnormalities in ocular hypertensive patients. Am J Ophthalmol. 2003;135: 131-7.
• Zimmerman R, Sakiyalak D, Krupin T. Primary open-angle glaucoma. Ophthalmology. Second Edition. Yanoff M, Duker JS, eds. Mosby. St Louis. 2004;1482-7.
• Oliver JE, Hattenhauer MG, Herman D, et al. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol. 2002;133(6): 764-72.
• Medeiros FA, Weinreb RN. Estimating the risk of developing glaucoma. Open Ophthalmol J. 2009;3: 50-3.
• Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117: 14-6.
• Singh RP, Goldberg I, Graham SL. Central corneal thickness, tonometry and ocular dimensions in glaucoma and ocular hypertension. J Glaucoma. 2001;10: 206-10.
• Atanassov MA, Konareva-Kostianeva MI. Central corneal thickness measurement in ocular hypertension, primary open angle, glaucoma suspects and control suspects. Folia Med. 2008;50: 35-9.
• Mitchell P, Hourihan F, Sandbach J. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology. 1999;106: 2010-5.
• Jonas JB, Wang YX, Dong L, et al. High myopia and glaucoma-like optic neuropathy. Asia Pac J Ophthalmol. 2020;9(3):234–8.
• Wilson MR, Hertzmark E, Walker AM. A case control study of risk factors in open angle glaucoma. Arch Ophthalmol. 1987;105: 1066-71.
• Wolfs RC, Klaver CC, Ramrattan RS. Genetic risk of primary open angle glaucoma. Population based familial aggregation study. Arch Ophthalmol. 1998;116(12): 1640-5.
• Bailey JN, Loomis SJ, Kang JH, et al. Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat. Genet. 2016;48: 189–94.
• Wong VH, Bui BV, Vingrys AJ. Clinical and experimental links between diabetes and glaucoma. Clin Exp Optom. 2011;94: 4–23.
• Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am. 2005;18: 383–95.
• Newman-Casey PA, Talwar N, Nan B, et al. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology. 2011;118(7): 1318-22.
• Song XY, Chen YY, Liu WT, et al. Atorvastatin reduces IOP in ocular hypertension in vivo and suppresses ECM in trabecular meshwork perhaps via FGD4. Int J Mol Med. 2022;49(6): 76.
• Kakigi C, Kasuga T, Wang SY, et al. Hypothyroidism and Glaucoma in The United States. PLoS One. 2015;10(7).